Musk's Neuralink says has FDA approval for study of brain implants in humans
Reuters, 26 May 2023
Elon Musk's brain-implant company Neuralink on Thursday said the U.S. Food and Drug Administration had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en